The 2016 guideline on the work-up of primary aldosteronism recommended that patients
with obstructive sleep apnea–hypopnea syndrome (OSAS) be screened. This study aimed to …

Background Patients with obstructive sleep apnea hypopnea syndrome (OSAHS) combined
with resistant hypertension (RH) have a high risk of developing primary aldosteronism (PA) …

Background Primary aldosteronism (PA) and obstructive sleep apnea (OSA) are both
causes for resistant hypertension and contribute to adverse cardiovascular outcome …

Context Investigating the co-occurrence of obstructive sleep apnea (OSA) and primary
aldosteronism (PA) is crucial for understanding their interrelation. Objective This work aimed …

The association between primary aldosteronism (PA) and obstructive sleep apnea (OSA)
has been a matter of debate. 2016 Endocrine Society guideline recommends screening for …

Obstructive sleep apnea (OSA) and primary aldosteronism (PA) often coexist in
hypertension, whereas whether hypertensive patients with OSA should be screened for PA …

A recent report demonstrated that the prevalence of obstructive sleep apnea (OSA) is 67.6%
among Caucasian and Chinese patients with primary aldosteronism (PA). Moreover, the …

Obstructive sleep apnoea (OSA) is known to commonly co-exist with primary aldosteronism
(PA), but it is unknown if treatment of PA improves sleep apnoea parameters in these …

Study Objectives: It has been suggested that there might be a pathophysiological link and
overlap between primary aldosteronism (PA) and obstructive sleep apnea (OSA). Therefore …

Background: We previously described a significant correlation between plasma aldosterone
concentration (PAC) and severity of obstructive sleep apnea (OSA) in patients with resistant …